171 related articles for article (PubMed ID: 16207841)
1. APOE-epsilon4 predisposes to cognitive dysfunction following uncomplicated carotid endarterectomy.
Heyer EJ; Wilson DA; Sahlein DH; Mocco J; Williams SC; Sciacca R; Rampersad A; Komotar RJ; Zurica J; Benvenisty A; Quest DO; Todd G; Solomon RA; Connolly ES
Neurology; 2005 Dec; 65(11):1759-63. PubMed ID: 16207841
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E-ε4 polymorphism and cognitive dysfunction after carotid endarterectomy.
Heyer EJ; Mergeche JL; Stern Y; Malone HR; Bruce SS; Ward JT; Sander Connolly E
J Clin Neurosci; 2014 Feb; 21(2):236-40. PubMed ID: 24139138
[TBL] [Abstract][Full Text] [Related]
3. APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.
Ballard CG; Morris CM; Rao H; O'Brien JT; Barber R; Stephens S; Rowan E; Gibson A; Kalaria RN; Kenny RA
Neurology; 2004 Oct; 63(8):1399-402. PubMed ID: 15505155
[TBL] [Abstract][Full Text] [Related]
4. Inducible nitric oxide synthase promoter polymorphism affords protection against cognitive dysfunction after carotid endarterectomy.
Yocum GT; Gaudet JG; Lee SS; Stern Y; Teverbaugh LA; Sciacca RR; Emala CW; Quest DO; McCormick PC; McKinsey JF; Morrissey NJ; Solomon RA; Connolly ES; Heyer EJ
Stroke; 2009 May; 40(5):1597-603. PubMed ID: 19286578
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in complement component 3 (C3F) and complement factor H (Y402H) increase the risk of postoperative neurocognitive dysfunction following carotid endarterectomy.
Gigante PR; Kotchetkov IS; Kellner CP; Haque R; Ducruet AF; Hwang BY; Solomon RA; Heyer EJ; Connolly ES
J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):247-53. PubMed ID: 20841369
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
Hsiung GY; Sadovnick AD; Feldman H
CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
[TBL] [Abstract][Full Text] [Related]
7. The Influence of the Apolipoprotein E (APOE) Gene on Subacute Post-Concussion Neurocognitive Performance in College Athletes.
Merritt VC; Rabinowitz AR; Arnett PA
Arch Clin Neuropsychol; 2018 Feb; 33(1):36-46. PubMed ID: 28541413
[TBL] [Abstract][Full Text] [Related]
8. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
Martins CA; Oulhaj A; de Jager CA; Williams JH
Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
[TBL] [Abstract][Full Text] [Related]
9. The effect of the APOE-epsilon4 allele and ACE-I/D polymorphism on cognition during a two-year follow-up in first-ever stroke patients.
Bour AM; Rasquin SM; Baars L; van Boxtel MP; Visser PJ; Limburg M; Verhey FR
Dement Geriatr Cogn Disord; 2010; 29(6):534-42. PubMed ID: 20606435
[TBL] [Abstract][Full Text] [Related]
10. Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders.
Ma F; Wang J; Miao R; Zhao W; Wang Q
Neuropsychobiology; 2011; 64(2):102-9. PubMed ID: 21701228
[TBL] [Abstract][Full Text] [Related]
11. APOE ε4 is associated with exacerbation of cognitive decline in patients with multiple sclerosis.
Shi J; Tu JL; Gale SD; Baxter L; Vollmer TL; Campagnolo DI; Tyry TM; Zhuang Y; Kuniyoshi SM
Cogn Behav Neurol; 2011 Sep; 24(3):128-33. PubMed ID: 21945984
[TBL] [Abstract][Full Text] [Related]
12. APOE genotype and cognitive decline in a middle-aged cohort.
Blair CK; Folsom AR; Knopman DS; Bray MS; Mosley TH; Boerwinkle E;
Neurology; 2005 Jan; 64(2):268-76. PubMed ID: 15668424
[TBL] [Abstract][Full Text] [Related]
13. Predictors of neurocognitive decline after carotid endarterectomy.
Mocco J; Wilson DA; Komotar RJ; Zurica J; Mack WJ; Halazun HJ; Hatami R; Sciacca RR; Connolly ES; Heyer EJ
Neurosurgery; 2006 May; 58(5):844-50; discussion 844-50. PubMed ID: 16639318
[TBL] [Abstract][Full Text] [Related]
14. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
[TBL] [Abstract][Full Text] [Related]
15. APOE-ε4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke: Population-Based Cohort Study.
Pendlebury ST; Poole D; Burgess A; Duerden J; Rothwell PM;
Stroke; 2020 Mar; 51(3):751-758. PubMed ID: 32070224
[TBL] [Abstract][Full Text] [Related]
16. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
17. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
18. Post-carotid endarterectomy neurocognitive decline is associated with cerebral blood flow asymmetry on post-operative magnetic resonance perfusion brain scans.
Wilson DA; Mocco J; D'Ambrosio AL; Komotar RJ; Zurica J; Kellner CP; Hahn DK; Connolly ES; Liu X; Imielinska C; Heyer EJ
Neurol Res; 2008 Apr; 30(3):302-6. PubMed ID: 17803842
[TBL] [Abstract][Full Text] [Related]
19. Is ApoE epsilon4 associated with cognitive functioning in African Americans diagnosed with Alzheimer Disease? An exploratory study.
Mount DL; Ashley AV; Lah JJ; Levey AI; Goldstein FC
South Med J; 2009 Sep; 102(9):890-3. PubMed ID: 19668025
[TBL] [Abstract][Full Text] [Related]
20. APOE influences vasospasm and cognition of noncomatose patients with subarachnoid hemorrhage.
Lanterna LA; Rigoldi M; Tredici G; Biroli F; Cesana C; Gaini SM; Dalprà L
Neurology; 2005 Apr; 64(7):1238-44. PubMed ID: 15824354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
